UNLOCK THE POWER OF THE VAULT

Carter Validus Appoints Jon Sajeski as Vice President of Healthcare Acquisitions

March 2, 2016

TAMPA, Fla.–(BUSINESS WIRE)–Carter Validus Advisors II, LLC (“Carter Validus”), the external advisor to Carter Validus Mission Critical REIT II, Inc. (“CVMCR II”), is proud to announce that Jon Sajeski has joined Carter Validus as Vice President of Healthcare Acquisitions. In this role, Jon will focus on growing CVMCR II’s portfolio of high-quality, income-producing healthcare properties in the U.S occupied by first-rate tenants with long-term leases.

Carter Validus Appoints Jon Sajeski as Vice President of Healthcare Acquisitions

Tweet this

Jon joins Carter Validus with over 12 years of experience in the healthcare real estate industry. He recently worked for Rendina Healthcare Real Estate where he had success in numerous roles including acquisitions, development, leasing, finance, and property management. He holds a B.S. in Finance and Real Estate from Florida State University.

“Jon brings a wealth of healthcare industry knowledge, relationships, and experience to Carter Validus. As we continue to expand our portfolio of high-quality data center and healthcare assets, we believe Jon will bring tremendous value to our healthcare real estate investment strategy,” said Michael Seton, Co-Chief Executive Officer of Carter Validus.

“Our commitment to building a high-quality portfolio of investments for our shareholders has always been the central point of our business strategy and Jon will be a valuable contributor in this area. He is a strong addition to our team and we are thrilled to welcome him to Carter Validus,” said John Carter, Co-Chief Executive Officer of Carter Validus.

Jon Sajeski may be contacted at jsajeski@cvreit.com.

About Carter Validus Mission Critical REIT II, Inc.

Carter Validus Mission Critical REIT II, Inc. is a public, non-traded company headquartered in Tampa, Florida that has elected to be taxed, and believes it qualifies, as a real estate investment trust. The Company intends to acquire mission critical real estate assets located throughout the United States and abroad. Mission critical real estate assets are purpose-built facilities designed to support the most essential operations of tenants. Carter Validus Mission Critical REIT II, Inc. intends to focus its acquisitions on mission critical assets in the data center and healthcare sectors. See www.cvmissioncriticalreitii.com for more information.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of federal securities laws and regulations. These forward-looking statements are identified by their use of terms and phrases such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “should,” “will” and other similar terms and phrases, including references to assumptions and forecasts of future results. Forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that may cause the actual results to differ materially from those anticipated at the time the forward-looking statements are made. Although the company believes the expectations reflected in such forward-looking statements are based upon reasonable assumptions, it can give no assurance that the expectations will be attained or that any deviation will not be material. The company undertakes no obligation to update any forward-looking statement contained herein to confirm the statement to actual results or changes in the company’s expectations.

Contacts

Carter Validus
Stacy Sheedy, 813-316-4292
Marketing Manager
ssheedy@cvreit.com

Article Located Here

Go Back
Ramón A. Rivera-Ramos
Blue Vault Nontraded REIT and Nontraded BDC Reviews
September 1, 2016

Blue Vault helps me to stay well informed on the financial status of both open and closed nontraded REITs and BDCs, so that I can help my clients better understand the product, before they make the decision to invest and after.